372 related articles for article (PubMed ID: 20543832)
1. Live attenuated influenza virus vaccines by computer-aided rational design.
Mueller S; Coleman JR; Papamichail D; Ward CB; Nimnual A; Futcher B; Skiena S; Wimmer E
Nat Biotechnol; 2010 Jul; 28(7):723-6. PubMed ID: 20543832
[TBL] [Abstract][Full Text] [Related]
2. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets.
Broadbent AJ; Santos CP; Anafu A; Wimmer E; Mueller S; Subbarao K
Vaccine; 2016 Jan; 34(4):563-570. PubMed ID: 26655630
[TBL] [Abstract][Full Text] [Related]
4. Generation of Live Attenuated Influenza Virus by Using Codon Usage Bias.
Fan RL; Valkenburg SA; Wong CK; Li OT; Nicholls JM; Rabadan R; Peiris JS; Poon LL
J Virol; 2015 Nov; 89(21):10762-73. PubMed ID: 26269186
[TBL] [Abstract][Full Text] [Related]
5. Recoding of the vesicular stomatitis virus L gene by computer-aided design provides a live, attenuated vaccine candidate.
Wang B; Yang C; Tekes G; Mueller S; Paul A; Whelan SP; Wimmer E
mBio; 2015 Mar; 6(2):. PubMed ID: 25827413
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccines.
Jang YH; Jung EJ; Byun YH; Lee KH; Lee EY; Lee YJ; Seong BL
Vaccine; 2013 Jul; 31(33):3339-46. PubMed ID: 23742997
[TBL] [Abstract][Full Text] [Related]
7. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
8. [Rescued influenza A virus with codon deoptimized NS1 gene is attenuated both in vitro and in vivo].
Luan S; Pan W; Li T; Yang H; Zhang B; Li F; Chen L
Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):720-6. PubMed ID: 19670641
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of pigs with a codon-pair bias de-optimized live attenuated influenza vaccine protects from homologous challenge.
Kaplan BS; Souza CK; Gauger PC; Stauft CB; Robert Coleman J; Mueller S; Vincent AL
Vaccine; 2018 Feb; 36(8):1101-1107. PubMed ID: 29366707
[TBL] [Abstract][Full Text] [Related]
11. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
[TBL] [Abstract][Full Text] [Related]
12. A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates.
Mueller S; Stauft CB; Kalkeri R; Koidei F; Kushnir A; Tasker S; Coleman JR
Vaccine; 2020 Mar; 38(14):2943-2948. PubMed ID: 32107060
[TBL] [Abstract][Full Text] [Related]
13. Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge.
Baz M; Boonnak K; Paskel M; Santos C; Powell T; Townsend A; Subbarao K
mBio; 2015 Oct; 6(5):e01487-15. PubMed ID: 26489862
[TBL] [Abstract][Full Text] [Related]
14. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
[TBL] [Abstract][Full Text] [Related]
15. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
[TBL] [Abstract][Full Text] [Related]
16. Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets.
Stauft CB; Yang C; Coleman JR; Boltz D; Chin C; Kushnir A; Mueller S
PLoS One; 2019; 14(10):e0223784. PubMed ID: 31609986
[TBL] [Abstract][Full Text] [Related]
17. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
[TBL] [Abstract][Full Text] [Related]
18. Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.
Nogales A; DeDiego ML; Topham DJ; Martínez-Sobrido L
J Virol; 2016 Jul; 90(14):6291-6302. PubMed ID: 27122587
[TBL] [Abstract][Full Text] [Related]
19. Synonymous Deoptimization of Foot-and-Mouth Disease Virus Causes Attenuation In Vivo while Inducing a Strong Neutralizing Antibody Response.
Diaz-San Segundo F; Medina GN; Ramirez-Medina E; Velazquez-Salinas L; Koster M; Grubman MJ; de los Santos T
J Virol; 2016 Feb; 90(3):1298-310. PubMed ID: 26581977
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
